SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Cancer och onkologi) srt2:(2000-2004)"

Sökning: hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Cancer och onkologi) > (2000-2004)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
21.
22.
  • Smeland, S, et al. (författare)
  • Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders
  • 2003
  • Ingår i: European Journal of Cancer. - IFAC & Elsevier Ltd.. - 1879-0852. ; 39:4, s. 488-494
  • Tidskriftsartikel (refereegranskat)abstract
    • From 1990 to 1997, 113 eligible patients with classical osteosarcoma received neo-adjuvant chemotherapy consisting of high-dose methotrexate, cisplatin and doxorubicin. Good histological responders continued to receive the same therapy postoperatively, while poor responders received salvage therapy with an etoposide/ifosfamide combination. With a median follow-up of 83 months, the projected metastasis-free and overall survival rates at 5 years are 63 and 74%, respectively. Independent favourable prognostic factors for outcome were tumour volume < 190 ml, 24-h serum methotrexate > 4.5 muM and female gender. The etoposide/ifosfamide replacement combination did not improve outcome in the poor histological responders. In conclusion, this intensive multi-agent chemotherapy results in > 70% of patients with classical osteosarcoma surviving for 5 years. The data obtained from this non-randomised study do not support discontinuation and exchange of all drugs used preoperatively in histological poor responders. As observed in previous Scandinavian osteosarcoma studies, female gender appears to be a strong predictor of a favourable outcome. (C) 2003 Elsevier Science Ltd. All rights reserved.
  •  
23.
24.
  • Jahnson, Staffan, et al. (författare)
  • Tumor mapping of regional immunostaining for p21, p53, and mdm2 in locally advanced bladder carcinoma
  • 2000
  • Ingår i: Cancer. - New York, USA : John Wiley & Sons. - 0008-543X. ; 89:3, s. 619-629
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: The aim of this study was to elucidate the associations among immunostaining for p53, p21, and mdm2; their respective expression within each tumor; and the value of these variables for predicting treatment outcome after cystectomy for patients with locally advanced bladder carcinoma.Methods: The hospital records from all 173 patients treated with cystectomy for locally advanced urothelial bladder carcinoma between 1967 and 1992 were retrospectively reviewed. Three consecutive sections from biopsies taken before any treatment were stained using the standard immunohistochemical technique for p53, p21, and mdm2, respectively. The cutoff limit was 20% or more for positive p53 expression and 10% or more for positive p21 and mdm2 expression.Results: Positive immunostaining was observed for p53 in 98 tumors (57%), for p21 in 89 tumors (51%), and for mdm2 in only 16 tumors (9%). The only association found between immunostaining for the three antibodies was that most mdm2-positive tumors had positive p21 expression. Tumor mapping of regional immunostaining showed no association between immunostaining for p53 and p21. In a proportional hazards analysis, no association was found between the results of immunostaining for the three antibodies and treatment outcome.Conclusions: Positive or negative expression of p53, p21, or mdm2, or combinations of these, was not associated with cancer specific mortality after cystectomy for bladder carcinoma. There was no association between immunostaining for p21 and p53, whereas positive immunostaining for mdm2 was observed in a minority of the tumors. These results indicate that, in addition to p21, p53, and mdm2, there are other oncoproteins and tumor suppressor proteins along the p53 pathway that are involved in tumor development and progression.
  •  
25.
  • Brun, Eva, et al. (författare)
  • FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma.
  • 2002
  • Ingår i: Head and Neck. - John Wiley & Sons. - 1043-3074. ; 24:2, s. 127-135
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Positron emission tomography (PET) provides metabolic information of tissues in vivo. The purpose of this study was to assess the value of PET with 2-[(18) F] fluoro-2-deoxy-D-glucose (FDG) in prediction of therapy outcome (tumor response, survival, and locoregional control) in locally advanced HNSCC. METHODS: Between 1993 and 1999 47 patients underwent PET before (PET(1)) and after (PET(2)) 1 to 3 weeks of radical treatment with evaluation of metabolic rate (MR) and standardized uptake value (SUV) of FDG. All patients received radiotherapy, and 10 also received neoadjuvant chemotherapy. Median follow-up time was 3.3 years. RESULTS: Low and high MR FDG at PET(2), with median value as cutoff, was associated with complete remission in 96% and 62% (p =.007), with 5-year overall survival in 72% and 35% (p =.0042) and with local control in 96% and 55% (p =.002), respectively. CONCLUSIONS: FDG PET in the early phase of treatment of HNSCC is associated with tumor response, survival, and local control. Copyright 2002 John Wiley & Sons, Inc.
  •  
26.
  • Jin, Yuesheng, et al. (författare)
  • Clonal chromosome abnormalities in premalignant lesions of the skin.
  • 2002
  • Ingår i: Cancer Genetics and Cytogenetics. - Elsevier. - 0165-4608. ; 136:1, s. 48-52
  • Tidskriftsartikel (refereegranskat)abstract
    • Two lesions, actinic keratosis (AK) and squamous cell carcinoma in situ (CIS), are believed to be precursors of squamous cell carcinoma (SCC) of the skin. These lesions can serve as an excellent model system for studying genetic changes associated with the inception of skin SCC. In the present study, five such lesions of the skin, three AKs and two AK+CIS, from three patients were short-term cultured and analyzed cytogenetically. One of the patients (case 3) had also an SCC in addition to three premalignant lesions. All lesions, but one, showed clonal karyotypic abnormalities. The recurrent changes identified were numerical, that is, +7 and +20. The structural rearrangements found in three AK were different, but it could be noted that the distal part of the long arm of chromosome 4 was involved in two AK and the SCC of case 3A. It was also interesting that chromosome 1 participated in structural rearrangements in three AK with band 1p31 being involved in two tumors. The karyotypic profile of these lesions is compared with that of skin SCC; it turns out that the general patterns are different in the sense that the SCC more often have complex karyotypes and display unbalanced aberrations involving the centromeric regions. Some karyotypic similarities between the SCC and their precursors are revealed. The fact that the structural rearrangements involving chromosomal band 3p13 and the centromeric region of chromosome 3 in AK are common features for many types of malignant tumors, including skin SCC, indicates that these changes are early genetic events associated with malignant transformation.
  •  
27.
  • Kreicbergs, Ulrika, et al. (författare)
  • Anxiety and depression in parents 4-9 years after the loss of a child owing to a malignancy: a population-based follow-up
  • 2004
  • Ingår i: Psychol Med. - 0033-2917. ; 34:8, s. 1431-41
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Some consider the loss of a child as the most stressful life event. When the death is caused by a malignancy, the parents are commonly exposed not only to their own loss, but also to the protracted physical and emotional suffering of the child. We investigated parental risk of anxiety and depression 4-9 years after the loss of a child owing to a malignancy.METHOD: In 2001, we attempted to contact all parents in Sweden who had lost a child due to a malignancy during 1992--1997. We used an anonymous postal questionnaire and utilized a control group of non-bereaved parents with a living child.RESULTS: Participation among bereaved parents was 449/561 (80 %); among non-bereaved 457/659 (69%). We found an increased risk of anxiety (relative risk 1.5, 95 % confidence interval 1.1-1.9) and depression (relative risk 1.4, 95 % confidence interval 1.1-1.7) among bereaved parents compared with non-bereaved. The risk of anxiety and depression was higher in the period 4-6 years after bereavement than in the 7-9 years period, during which the average excess risks approached zero. Psychological distress was overall higher among bereaved mothers and loss of a child aged 9 years or older implied an increased risk, particularly for fathers.CONCLUSIONS: Psychological morbidity in bereaved parents decreases to levels similar to those among non-bereaved parents 7-9 years after the loss. Bereaved mothers and parents who lose a child 9 years or older have on average an excess risk for long-term psychological distress.
  •  
28.
  • Johansson, Bengt, 1958-, et al. (författare)
  • Phantom study of radiation doses outside the target volume brachytherapy versus external radiotherapy of early breast cancer
  • 2003
  • Ingår i: Radiotherapy and Oncology. - Amsterdam : Elsevier. - 0167-8140. ; 69:1, s. 107-112
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND AND PURPOSE: Brachytherapy is sometimes suggested as an adjuvant treatment after surgery of some tumours. When introducing this, it would be useful to have an estimate of the dose distribution to different body sites, both near and distant to target, comparing conventional external irradiation to brachytherapy. The aim of the present study was to determine radiation doses with both methods at different body sites, near and distant to target, in an experimental situation on an operated left sided breast cancer on a female Alderson phantom. METHODS: Five external beam treatments with isocentric tangential fields were given by a linear accelerator. A specified dose of 1.0 Gy was given to the whole left sided breast volume. Five interstitial brachytherapy treatments were given to the upper, lateral quadrant of the left breast by a two plane, 10 needles implant. A dose of 1.0 Gy specified according to the Paris system was administered by a pulsed dose rate afterloading machine. Absorbed dose in different fixed dose points were measured by thermoluminescence dosimeters. RESULTS: Both methods yielded an absorbed dose of the same size to the bone marrow and internal organs distant to target, 1.0-1.4% of the prescribed dose. There was a trend of lower doses to the lower half of the trunk and higher doses to the upper half of the trunk, respectively, by brachytherapy. A 90% reduction of absorbed dose with brachytherapy compared to external irradiation was found in the near-target region within 5 cm from target boundary where parts of the left lung and the heart are situated. If an adjuvant dose of 50 Gy is given with the external radiotherapy and brachytherapy, the absorbed dose in a part of the myocardium could be reduced from 31.8 to 2.1 Gy. CONCLUSIONS: Near target, brachytherapy yielded a considerably lower absorbed dose which is of special importance when considering radiation effects on the myocard and lungs. We could not demonstrate any difference of importance, in absorbed dose to dose points distant to target.
  •  
29.
  • Kaaks, Rudolf, et al. (författare)
  • Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden
  • 2002
  • Ingår i: Cancer Causes and Control. - Springer. - 1573-7225. ; 13:4, s. 307-316
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: To examine the possible relationships of breast cancer risk to prediagnostic plasma levels of insulin; insulin-like growth factor-I (IGF-I); and IGF-binding proteins -1, -2, and -3. Methods: Within two prospective cohorts in Umea and Malmo we measured plasma concentrations of insulin, IGF-I, and IGFBPs for a total of 513 incident breast cancer cases and 987 matched controls. Results: Globally, risk was unassociated with levels of IGF-I, IGFBP-3, or IGF-I adjusted for IGFBP-3. When breaking down the analysis by subgroups of age at blood donation, an increase in risk was observed for increasing levels of IGF-I in women aged 55 or older, in the Umea cohort only (odds ratios of 1.00, 1.73, 1.76, 1.90; p(trend) = 0.05). This effect weakened, however, when the analysis was restricted to subjects who did not use exogenous hormones for the treatment of menopausal symptoms. Levels of IGF-I and IGFBP-3 were not related to risk in younger women, recruited before age 50, contrary to observations from previous studies. In a subcohort where blood samples had been collected after at least four hours of fasting, breast cancer risk showed no clear associations with levels of insulin, IGFBP-1, or IGFBP-2. Conclusions: Our results do not confirm earlier findings of an association of plasma IGF-I levels with breast cancer risk especially in young women, but suggest a possible association with postmenopausal breast cancer risk, possibly among ERT/HRT users only. Our results do not support the hypothesis that elevated plasma insulin levels, and reduced levels of IGFBP-1 and IGFBP-2, are associated with increased breast cancer risk.
  •  
30.
  • Ahlman, Håkan, 1947-, et al. (författare)
  • Liver transplantation for treatment of metastatic neuroendocrine tumors
  • 2004
  • Ingår i: Annals of the New York Academy of Sciences. - 0077-8923 (Print). ; 1014, s. 265-9
  • Tidskriftsartikel (refereegranskat)abstract
    • Liver transplantation can be considered a therapeutic option for patients with neuroendocrine tumors only metastatic to the liver. Important selection criteria are well-differentiated tumors and a low proliferation rate (Ki67 <10%). In this series, orthopic liver transplantation offered good relief of symptoms and long disease-free intervals with initial survival of grafts and patients as in benign disease. The experience with multivisceral transplantation is still limited.
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (244)
Typ av publikation
tidskriftsartikel (865)
doktorsavhandling (74)
konferensbidrag (21)
forskningsöversikt (19)
bokkapitel (12)
annan publikation (1)
visa fler...
rapport (1)
visa färre...
Typ av innehåll
refereegranskat (867)
övrigt vetenskapligt (143)
populärvet., debatt m.m. (1)
Författare/redaktör
Olsson, Håkan, (49)
Borg, Åke, (42)
Li, Xinjun, (33)
Fernö, Mårten, (29)
Mertens, Fredrik, (29)
Möller, Torgil, (28)
visa fler...
Cavallin-Ståhl, Eva, (26)
Mandahl, Nils, (24)
Bendahl, Pär Ola, (23)
Glimelius, Bengt, (20)
Berglund, Göran, (20)
Hemminki, K (20)
Nilbert, Mef, (19)
Landberg, Göran (18)
Baldetorp, Bo, (18)
Larsson, Christer, (17)
Hemminki, Kari, (17)
Anderson, Harald (17)
Påhlman, Sven, (16)
Åkerman, Måns, (16)
Tennvall, Jan, (16)
Dasu, Alexandru (16)
Dillner, Joakim, (15)
Domanski, Henryk, (15)
Lennernäs, Bo, 1963- ... (14)
Blomqvist, Carl, (13)
Ahlman, Håkan, 1947- ... (13)
Strand, Sven-Erik, (13)
Hultborn, Ragnar, 19 ... (12)
Svanberg, Katarina, (12)
Wängberg, Bo, 1953-, (12)
Ringnér, Markus, (12)
Alvegård, Thor, (12)
Toma-Dasu, Iuliana, (12)
Axelson, Håkan, (12)
Stenram, Unne, (11)
Manjer, Jonas (11)
Mitelman, Felix, (11)
Nilsson, Ola, 1957-, (10)
Mattsson, Sören, (10)
Kjellén, Elisabeth (10)
Hallmans, Göran, (10)
Albertsson, Maria (10)
Härkönen, Pirkko, (10)
Gustafson, Pelle, (10)
Janzon, Lars, (10)
Willen, R. (10)
Dictor, Michael (10)
Wennerberg, Johan, (10)
Jernström, Helena (10)
visa färre...
Lärosäte
Lunds universitet (705)
Karolinska Institutet (167)
Göteborgs universitet (135)
Uppsala universitet (101)
Umeå universitet (71)
Linköpings universitet (55)
visa fler...
Örebro universitet (27)
Stockholms universitet (9)
Södertörns högskola (6)
Ersta Sköndal Bräcke högskola (3)
Kungliga Tekniska Högskolan (2)
Högskolan i Jönköping (2)
Malmö universitet (2)
Högskolan i Halmstad (2)
Linnéuniversitetet (2)
Högskolan i Skövde (1)
Högskolan i Borås (1)
Högskolan i Gävle (1)
Blekinge Tekniska Högskola (1)
Röda Korsets Högskola (1)
visa färre...
Språk
Engelska (979)
Svenska (12)
Kinesiska (1)
Annat språk (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (993)
Naturvetenskap (13)
Samhällsvetenskap (3)
Teknik (2)
Humaniora (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy